版本:
中国

BRIEF-Botanix Pharmaceuticals receives U.S. export approval of drug for clinical studies

March 24 Botanix Pharmaceuticals Ltd

* Receives export and import approvals for clinical studies

* U.S. Drug Enforcement Agency approved export, Australian Office Of Drug Control approved import of synthetic cannabidiol for planned clinical studies Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐